Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zostavax in Cirrhotic Subjects
NCT02958345Phase 4Completed
- Sponsor
- Tulane University
- Start
- Jun 2013
- Primary completion
- Jul 2015
- Modality
- Live Attenuated Vaccines
01
Overview
Phase 4, randomised, double-blind trial in herpes zoster (HZ) comparing Zostavax with Placebo (2 arms). Primary endpoint: Interferon-G Enzyme-Linked Immunospot Assay at 6 weeks. Started Jun 2013; status: completed.
02
Drugs
zoster vaccine, live
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on NCT02958345.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02958345.